コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in pathogenicity between vaccinia virus and variola virus.
2 virulence mechanisms of the causative agent, variola virus.
3 dvantage that it can simultaneously identify variola virus.
4 irus (ECTV), the murine counterpart to human variola virus.
5 eacted with OPG153 orthologs from cowpox and variola viruses.
6 camelpox, cowpox, ectromelia (mousepox), and variola viruses.
7 pitopes are highly conserved in vaccinia and variola viruses.
8 ed genomic DNA from 48 different isolates of variola virus; 25 different strains and isolates of came
11 as a global illness more than 30 years ago, variola virus and other related pathogenic poxviruses, s
12 bubonic plague (Yersinia pestis), smallpox (Variola virus) and cholera (Vibrio cholerae) - and for t
13 epitopes are completely conserved among VV, variola viruses, and most mammalian poxviruses, includin
15 hage host range protein, myxoma virus M011L, variola virus B22R, four ankyrin repeat proteins, three
18 naturally occurring systemic infection with variola virus both lead to the characteristic skin "pox"
19 d mouth disease virus (n=2 each, 12.5%); and variola virus, Burkholderia pseudomallei, and influenza
21 Of the 43 samples that contained purified variola virus DNA ranging in concentration from 1 fg/ mi
25 The Poxviridae family members vaccinia and variola virus enter mammalian cells, replicate outside t
27 e sequences of 24 strains of smallpox virus (variola virus), for rapid characterization of this human
28 lpox) in a scenario involving the release of variola virus from a laboratory, 19 deaths in a human-ve
32 amino acid differences compared with its B6 variola virus homologue, B6 might be a better choice for
33 ata suggest that a subunit vaccine using the variola virus homologues might exhibit improved protecti
34 interaction, in contrast to results for the Variola virus IL-18BP, which has been shown to primarily
36 erived from virus-infected cell cultures and variola virus-infected tissues; thus, the DNA material c
39 n magnitude to that achieved through natural variola virus infection, and this may explain the notabl
42 the disease is essential because its cause, variola virus, is considered a potential biological weap
43 tive genomics of 45 epidemiologically varied variola virus isolates from the past 30 years of the sma
44 the 14-kDa fusion protein gene of each of 14 variola virus isolates of the Russian World Health Organ
45 74-82), which is shared between vaccinia and variola viruses, may be a CD8(+) T-cell epitope of vacci
50 time polymerase-chain-reaction assay for non-variola virus orthopoxviruses were positive, and DNA seq
51 eins encoded by the ectromelia virus and the variola virus possess E3 ubiquitin ligase activity in bi
52 te that despite the enhanced activity of the variola virus protein, its cofactor activity in the fact
53 protein interaction screening of the unique variola virus proteome by using yeast 2-hybrid screening
60 , we detail the design and validation of two variola virus-specific real-time PCR assays, since previ
61 encing GeneChips for the rapid sequencing of Variola virus strains in the WHO Repository of the Cente
62 ratures (T(m)s) determined for 46 strains of variola virus (T(m)s, 55.9 to 57.8 degrees C) differed s
63 etected among the 116 samples not containing variola virus tested; i.e., the overall specificity of t
65 jority of the orthopoxviruses, including the variola virus that causes the dreaded smallpox disease,
67 ths of genotypic host adaptation resulted in variola viruses that circulated widely among humans.
68 eal a now-extinct sister clade of the modern variola viruses that were in circulation before the erad
69 duce the spread of vaccinia virus as well as variola virus (the causative agent of smallpox) in vitro
70 ited the spread of vaccinia virus as well as variola virus (the causative agent of smallpox) in vitro
73 (OPVs), which include the agent of smallpox (variola virus), the zoonotic monkeypox virus, the vaccin
77 stablished as the result of the concern that variola virus, the causative agent of smallpox, as well
82 T-lymphocyte (CTL) epitopes are defined for variola virus, the causative agent of smallpox, or for v
90 ilarity between the proteins of vaccinia and variola viruses, these new inhibitors are anticipated to
93 contains other pathogenic viruses including variola virus, vaccinia virus, camelpox virus, and cowpo
94 man infections on an intermittent basis, and variola virus (VARV) has potential for use as an agent o
95 dae family members monkeypox virus (MPX) and variola virus (VarV) use conserved mechanisms for actin
96 mescale of emergence of the causative agent, variola virus (VARV), and how it evolved in the context
100 O) vaccination campaign in the 1970s and the variola virus was restricted to repositories in the Unit